A Study of LY3305677 in Participants With Obesity Or Overweight

NCT05623839 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: LY3305677
DRUG: Placebo

Sponsor

Eli Lilly and Company